This page shows information from a previous legislative session and is presented for archive purposes only.

HB2039 - AN ACT REGARDING SALES LIMITS FOR EPHEDRINE.


Bill Number:
HB2039 PDF
HB2039
Act Number:
Act 712 PDF
712
Status:
House--Notification that HB2039 is now Act 712
Originating Chamber:
House
Lead Sponsor:
Introduction Date:
3/9/2009 10:11:00 AM
Act Date:
3/31/2009

Upcoming Events

No upcoming events for this bill.


Bill Status History

Chamber
Date
Action
Vote
House
3/31/2009 10:56:12 AM
Notification that HB2039 is now Act 712
House
3/26/2009 3:21:44 PM
Correctly enrolled and ordered transmitted to the Governor's Office.
House
3/26/2009 1:56:15 PM
TO BE ENROLLED
House
3/26/2009 1:56:02 PM
Returned From the Senate as passed.
Senate
3/26/2009 12:31:07 PM
Returned to the House as passed.
Senate
3/26/2009 12:30:43 PM
Read the third time and passed.
Senate
3/25/2009 1:50:12 PM
Returned by the Committee, with the recommendation that it Do Pass
Senate
3/16/2009 2:55:46 PM
Read first time, rules suspended, read second time, referred to Senate Committee on Judiciary
Senate
3/16/2009 2:55:32 PM
Received from the House.
House
3/13/2009 10:39:15 AM
Read the third time and passed and ordered transmitted to the Senate.
House
3/12/2009 1:53:17 PM
Returned by the Committee Do Pass
House
3/9/2009 2:57:01 PM
Read the first time, rules suspended, read the second time and referred to the Committee on PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE- HOUSE
House
3/9/2009 10:11:31 AM
Filed

BLR Fiscal Impacts

FI Number
Requestor
Date Issued
Document
FI1
3/12/2009